• AAPS-2011 *Enhanced HPLC/Mass Spectrometric Sensitivity of Retinoid Carboxylic Acids by Derivatization of the Acid Group with Amines.

• AAPS-2010 *Quantitative Determination of Paclitaxel in Human Whole Blood (HWB) Dried Blood SPots (DBS) using LC/MS/MS.

• AAPS-2010 *Analysis of Non-Encapsulated and Liposome Encapsulated Vincristine in Human Plasma.

• Applied Pharmaceutical Analysis 2010 *Quantitation of the Synthetic Prostacyclin Beraprost, Total Beraprost and the Active 314d Stereoisomer.

• Intertek-Alta Bioanalytical Symposium San Francisco, CA June 9th 2010.

• ASMS-2010 *Analysis and Stabilization of MTIC, the Biologically Active Hydrolysis Product of the Antitumor Pro-Drug Temozolomide, in Plasma and Whole Blood.

•  4TH Workshop in Regulated Bioanalysis, April-2010 *Comparison of 1/x2 & 1/x weighting for Standard Curves of Pharmaceutical PK/TK Data.

• ASMS-2009 *LL Extraction along with Colloidal Silica and Polyvalent Cations to Remove Phospholipids.

• ASMS-2009 *HPLC/MS/MS with In-Source Collision Induced Dissociation for Direct Measurement of PEGylated Compounds in Biological Matrices.

• ASMS-2008 *Enhanced LC/MS Detection of a Benzoxaborole by Derivatization with (+) Pinanediol.

• ASMS-2008 *Automated Screening System for Solvent and Column Selections to Minimize Carryover.

• AAPS-2006 *Validation and High Throughput Analysis of Ranolazine in Human Plasma Using Automated Liquid Handeling Robotics.

• ASMS-2006 *Phospholipid Matrix Effects - LUDOX AS-40 Colloidal Silica & Manganese(II) Chloride.

• ASMS-2006 *Weak-Reversed-Phase Retention on Silica Column to Remove Matrix Suppression.

• ASMS-2006 *Measurement of PEGylated Compounds in Dog Plasma.

• 21CFR Part 11 Document Control

• Version Control Reporting Process